These compounds may interact with:
Peroxisome proliferator-activated receptor gamma
Potentially involved in: familial partial lipodystrophy; diabetes mellitus; obesity; acquired metabolic disease; carcinoma; type 2 diabetes mellitus; atherosclerosis; cancer; lipid metabolism disorder; hyperglycemia; lipodystrophy; hypertension; fatty liver disease; hyperinsulinism; inflammatory bowel disease; kidney disease; osteoporosis; coronary artery disease; alzheimer's disease; heart disease
Disease data sourced from Pharos.